JNJ's Independent Rise: A Strong Story Behind the Numbers

Johnson & Johnson (JNJ) has been a standout performer in recent times, gaining 4.4% over the last five trading days while the S&P 500 slipped 0.5%. The stock's strong performance is largely due to its own unique story rather than being driven by market trends.

Over the past five years, JNJ has shown a correlation of just 0.16 with the S&P 500, indicating that it moves independently of the broader market. This independence comes at a cost, however, as the stock's annualized return over this period was 11.8%, compared to 13.2% for the index.

The company's business model is largely driven by its own product calendar, with management highlighting that it has 28 platforms generating more than $1 billion in annual sales. Operational sales grew 5.6% in the second quarter of 2026, despite a significant decline in STELARA sales due to biosimilar competition.

JNJ's performance is not just about its own growth, but also about how it moves in relation to the market. On days when the S&P 500 rose over the past year, JNJ captured only about 1% of the market's gain, while on days when the market fell, the stock moved about 65% in the opposite direction.